| Aggregate Evidence Quality . | Grade B (Evidence Level A in Adults) . |
|---|---|
| Benefits | Improved diagnosis of WCH and the benefit of fewer additional laboratory tests and/or treatment of primary HTN. Costs might be reduced if the treatment of those misdiagnosed as hypertensive is prevented |
| Risks, harm, cost | Additional costs; costs may not be covered by insurance companies. The ambulatory BP monitor is uncomfortable for some patients |
| Benefit–harm assessment | Benefit exceeds risk |
| Intentional vagueness | None |
| Role of patient preferences | Important; some patients may not want to undergo ABPM. Benefits of the procedure should be reviewed with families to assist in decision-making |
| Exclusions | None |
| Strength | Strong recommendation |
| Key references | 206 |
| Aggregate Evidence Quality . | Grade B (Evidence Level A in Adults) . |
|---|---|
| Benefits | Improved diagnosis of WCH and the benefit of fewer additional laboratory tests and/or treatment of primary HTN. Costs might be reduced if the treatment of those misdiagnosed as hypertensive is prevented |
| Risks, harm, cost | Additional costs; costs may not be covered by insurance companies. The ambulatory BP monitor is uncomfortable for some patients |
| Benefit–harm assessment | Benefit exceeds risk |
| Intentional vagueness | None |
| Role of patient preferences | Important; some patients may not want to undergo ABPM. Benefits of the procedure should be reviewed with families to assist in decision-making |
| Exclusions | None |
| Strength | Strong recommendation |
| Key references | 206 |